Veterinary Medicines

Marbonor 100 mg/ml Solution for Injection for cattle and pig

Authorised
  • Marbofloxacin
Download as PDF

Product identification

Medicine name:
Marbonor 100 mg/ml Solution for Injection for cattle and pig
Marbonor 100 mg/ml raztopina za injiciranje za govedo in prašiče
Active substance:
  • Marbofloxacin
Target species:
  • Cattle
  • Pig
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Marbofloxacin
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        6
        day
      • Milk
        36
        hour
    • Pig
      • Meat and offal
        4
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        6
        day
      • Milk
        36
        hour
  • Subcutaneous use
    • Cattle
      • Meat and offal
        6
        day
      • Milk
        36
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA93
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Package description:
  • The product is packaged in 60 ml amber co-ex plastic (polypropylene) vial.Vial is closed with chlorobutyl rubber stopper sealed with aluminium cap.
  • The product is packaged in 500 ml amber type II glass vial.Vial is closed with chlorobutyl rubber stopper sealed with aluminium cap.
  • The product is packaged in 250 ml amber type II glass vial.Vial is closed with chlorobutyl rubber stopper sealed with aluminium cap.
  • The product is packaged in 100 ml amber type II glass vial.Vial is closed with chlorobutyl rubber stopper sealed with aluminium cap.
  • The product is packaged in 50 ml amber type II glass vial.Vial is closed with chlorobutyl rubber stopper sealed with aluminium cap.
  • The product is packaged in 20 ml amber type II glass vial.Vial is closed with chlorobutyl rubber stopper sealed with aluminium cap.
  • The product is packaged in 100 ml amber co-ex plastic (polypropylene) vial.Vial is closed with chlorobutyl rubber stopper sealed with aluminium cap.
  • The product is packaged in 250 ml amber co-ex plastic (polypropylene) vial.Vial is closed with chlorobutyl rubber stopper sealed with aluminium cap.
  • The product is packaged in 500 ml amber co-ex plastic (polypropylene) vial.Vial is closed with chlorobutyl rubber stopper sealed with aluminium cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Manufacturing Limited
  • Norbrook Laboratories Limited
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • DC/V/0414/001
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0296/001
Concerned member states:
  • Cyprus
  • Czechia
  • Estonia
  • Finland
  • Greece
  • Hungary
  • Latvia
  • Romania
  • Slovakia
  • Slovenia
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 16/01/2026
Download
Slovenian (PDF)
Published on: 5/09/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 5/09/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 5/09/2025
Download

Combined File of all Documents

English (PDF)
Published on: 28/09/2025
Download